[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Table 1. 
Diagnostic Criteria for Autistic Disorder*
Diagnostic Criteria for Autistic Disorder*
Table 2. 
Autism-Specific Screening Tools
Autism-Specific Screening Tools
Table 3. 
Professionals Who May Be Included in Multidisciplinary Assessment for Autism
Professionals Who May Be Included in Multidisciplinary Assessment for Autism
Table 4. 
Autism-Specific Diagnostic Tools
Autism-Specific Diagnostic Tools
Table 5. 
Cognitive Assessment Tools
Cognitive Assessment Tools
Table 6. 
Medical and Genetic Evaluation of Children With Autism
Medical and Genetic Evaluation of Children With Autism
1.
Barbaresi  WJKatusic  SKColligan  RCWeaver  ALJacobsen  SJ The incidence of autism in Olmsted County, Minnesota, 1976-1997: results from a population-based study  Arch Pediatr Adolesc Med 2005;15937- 44PubMedArticle
2.
Stratton  KedGable  AedShetty  PedMcCormich  Med Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism.  Washington, DC National Academy Press2001;
3.
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision.  Washington, DC American Psychiatric Association2000;
4.
Kanner  L Autistic disturbances of affective contact  Nervous Child 1943;2217- 250
5.
New York State Department of Health Early Intervention Program, Clinical Practice Guideline: Report of the Recommendations, Autism/Pervasive Developmental Disorders.  Albany New York State Dept of Health, Health Education Services1999;
6.
Lord  CRisi  S Frameworks and methods in diagnosing autism spectrum disorders  Ment Retard Dev Disabil Res Rev 1998;490- 96Article
7.
Filipek  PAAccardo  PJBaranek  GT  et al.  The screening and diagnosis of autistic spectrum disorders [published correction appears in J Autism Dev Disord. 2000;30:81]  J Autism Dev Disord 1999;29439- 484PubMedArticle
8.
Lord  CVolkmar  F Genetics of childhood disorders, XLII: autism, part 1: diagnosis and assessment in autistic spectrum disorders  J Am Acad Child Adolesc Psychiatry 2002;411134- 1136PubMedArticle
9.
Wing  LGould  J Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification  J Autism Dev Disord 1979;911- 29PubMedArticle
10.
Beglinger  LSmith  T Concurrent validity of social subtype and IQ after early intensive behavioral intervention in children with autism: a preliminary investigation  J Autism Dev Disord 2005;35295- 303PubMedArticle
11.
Volkmar  FChawarska  KKlin  A Autism in infancy and early childhood  Annu Rev Psychol 2005;56315- 336PubMedArticle
12.
Volkmar  FRLord  CBailey  ASchultz  RTKlin  A Autism and pervasive developmental disorders  J Child Psychol Psychiatry 2004;45135- 170PubMedArticle
13.
Wing  LPotter  D The epidemiology of autistic spectrum disorders: is the prevalence rising?  Ment Retard Dev Disabil Res Rev 2002;8151- 161PubMedArticle
14.
Fombonne  ESimmons  HFord  TMeltzer  HGoodman  R Prevalence of pervasive developmental disorder in the British nationwide survey of child mental health  J Am Acad Child Adolesc Psychiatry 2001;40820- 827PubMedArticle
15.
Fombonne  E The prevalence of autism  JAMA 2003;28987- 89PubMedArticle
16.
Yeargin-Allsopp  MRice  CKarapurkar  TDoernberg  NBoyle  CMurphy  C Prevalence of autism in a US metropolitan area  JAMA 2003;28949- 55PubMedArticle
17.
Bertrand  JMars  ABoyle  CBove  FYeargin-Allsopp  MDecoufle  P Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation  Pediatrics 2001;1081155- 1161PubMedArticle
18.
Gernsbacher  MDawson  MGoldsmith  H Three reasons not to believe in an autism epidemic  Curr Dir Psychol Sci 2005;1455- 58Article
19.
Newschaffer  CJFalb  MDGurney  JG National autism prevalence trends from United States special education data  Pediatrics 2005;115e277- e282PubMedArticle
20.
Nelson  KBBauman  ML Thimerosal and autism?  Pediatrics 2003;111674- 679PubMedArticle
21.
Smeeth  LCook  CFombonne  PE  et al.  Rate of first recorded diagnosis of autism and other pervasive developmental disorders in United Kingdom general practice, 1988 to 2001  BMC Med 2004;239PubMedArticle
22.
Lipkin  PHSchertz  MCapute  AJedAccardo  PJed An assessment of the efficacy of early intervention programs  Developmental Disabilities in Infancy and Childhood. 2nd ed. Baltimore, Md Brookes Publishing Co1996;525- 547
23.
American Academy of Pediatrics,; Council on Children with Disabilities, Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening  Pediatrics 2006;118405- 420PubMedArticle
24.
American Academy of Pediatrics, Committee on Children with Disabilities, The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children  Pediatrics 2001;1071221- 1226PubMedArticle
25.
Baron-Cohen  SAllen  JGillberg  C Can autism be detected at 18 months? the needle, the haystack, and the CHAT  Br J Psychiatry 1992;161839- 843PubMedArticle
26.
Baron-Cohen  SWheelwright  SCox  A  et al.  Early identification of autism by the CHecklist for Autism in Toddlers (CHAT)  J R Soc Med 2000;93521- 525PubMed
27.
Berument  SKRutter  MLord  CPickles  ABailey  A Autism screening questionnaire: diagnostic validity  Br J Psychiatry 1999;175444- 451PubMedArticle
28.
Rutter  MBailey  ALord  C SCQ: Social Communication Questionnaire.  Los Angeles, Calif Western Psychological Services2003;
29.
Osterling  JDawson  G Early recognition of children with autism: a study of first birthday home videotapes  J Autism Dev Disord 1994;24247- 257PubMedArticle
30.
Mars  AEMauk  JEDowrick  P Symptoms of pervasive developmental disorders as observed in prediagnostic home videos of infants and toddlers  J Pediatr 1998;132500- 504PubMedArticle
31.
Werner  EDawson  GOsterling  JDinno  N Brief report: recognition of autism spectrum disorder before one year of age: a retrospective study based on home videotapes  J Autism Dev Disord 2000;30157- 162PubMedArticle
32.
Baranek  GT Autism during infancy: a retrospective video analysis of sensory-motor and social behaviors at 9-12 months of age  J Autism Dev Disord 1999;29213- 224PubMedArticle
33.
Baird  GCharman  TBaron-Cohen  S  et al.  A screening instrument for autism at 18 months of age: a 6-year follow-up study  J Am Acad Child Adolesc Psychiatry 2000;39694- 702PubMedArticle
34.
Chouieri  RBridgemohan  C To make the biggest difference, screen early for autism spectrum disorders  Contemp Pediatr 2005;2254- 64
35.
Robins  DLFein  DBarton  MLGreen  JA The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders  J Autism Dev Disord 2001;31131- 144PubMedArticle
36.
Dumont-Mathieu  TFein  D Screening for autism in young children: the Modified Checklist for Autism in Toddlers (M-CHAT) and other measures  Ment Retard Dev Disabil Res Rev 2005;11253- 262PubMedArticle
37.
Siegel  B Pervasive Developmental Disorders Screening Test—II.  San Antonio, Tex Harcourt Assessment Inc2004;
38.
Stone  WLCoonrod  EETurner  LMPozdol  SL Psychometric properties of the STAT for early autism screening  J Autism Dev Disord 2004;34691- 701PubMedArticle
39.
Lockyer  LRutter  M A five- to fifteen-year follow-up study of infantile psychosis, IV: Patterns of cognitive ability  Br J Soc Clin Psychol 1970;9152- 163PubMedArticle
40.
Happe  FGE Wechsler IQ profile and theory of mind in autism: a research note  J Child Psychol Psychiatry 1994;351461- 1471PubMedArticle
41.
Dennis  MLockyer  LLazenby  ALDonnelly  REWilkinson  MSchoonheyt  W Intelligence patterns among children with high-functioning autism, phenylketonuria, and childhood head injury  J Autism Dev Disord 1999;295- 17PubMedArticle
42.
Joseph  RMTager-Flusberg  HLord  C Cognitive profiles and social-communicative functioning in children with autism spectrum disorder  J Child Psychol Psychiatry 2002;43807- 821PubMedArticle
43.
Ehlers  SNyden  AGillberg  C  et al.  Asperger syndrome, autism, and attention disorders: a comparative study of the cognitive profiles of 120 children  J Child Psychol Psychiatry 1997;38207- 217PubMedArticle
44.
Klin  AVolkmar  FRSparrow  SSCicchetti  DVRourke  BP Validity and neuropsychological characterization of Asperger syndrome: convergence with nonverbal learning disabilities syndrome  J Child Psychol Psychiatry 1995;361127- 1140PubMedArticle
45.
Mayes  SDCalhoun  SL Similarities and differences in Wechsler intelligence Scale for Children, third edition (WISC-III) profiles: support for subtest analysis in clinical referrals  Clin Neuropsychol 2004;18559- 572PubMedArticle
46.
Mayes  SDCalhoun  SL Ability profiles in children with autism: influence of age and IQ  Autism 2003;765- 80PubMedArticle
47.
Mayes  SDCalhoun  SL Analysis of WISC-II, Stanford–Binet IV, and academic achievement test scores in children with autism  J Autism Dev Disord 2003;33329- 341PubMedArticle
48.
Shah  AFrith  U Why do autistic individuals show superior performance on the block design task?  J Child Psychol Psychiatry 1993;341351- 1364PubMedArticle
49.
Voigt  RGChilders  DODickerson  CL  et al.  Early pediatric neurodevelopmental profile of children with autistic spectrum disorders  Clin Pediatr (Phila) 2000;39663- 668PubMedArticle
50.
Voigt  RGAccardo  PJedCapute  AJed The Capute Scales in research  The Capute Scales. Baltimore, Md Brookes Publishing Co2005;41- 46
51.
Accardo  PJedCapute  AJed The Capute Scales.  Baltimore, Md Brookes Publishing Co2005;
52.
Lord C, McGee JP, eds, for the Committee on Educational Interventions for Children with Autism, Division of Behavioral and Social Sciences and Education, National Research Council, Educating Children With Autism.  Washington, DC National Academy Press2001;
53.
Individuals with Education Disabilities Act,,Public Law 105-117 (1997)
54.
Lord  CRutter  MLe Couteur  A Autism Diagnostic Interview–Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders  J Autism Dev Disord 1994;24659- 685PubMedArticle
55.
Klinger  LGRenner  P Performance-based measures in autism: implications for diagnosis, early detection, and identification of cognitive profiles  J Clin Child Psychol 2000;29479- 492PubMedArticle
56.
Lord  CPickles  AMcLennan  J  et al.  Diagnosing autism: analyses of data from the Autism Diagnostic Interview  J Autism Dev Disord 1997;27501- 517PubMedArticle
57.
Lord  CRisi  SLambrecht  L  et al.  The Autism Diagnostic Observation Schedule–Generic: a standard measure of social and communication deficits associated with the spectrum of autism  J Autism Dev Disord 2000;30205- 223PubMedArticle
58.
Gilliam  J Gilliam Autism Rating Scale (GARS).  Austin, Tex PRO-ED, Inc1995;
59.
Schopler  EReichler  RRochen-Renner  B The Childhood Autism Rating Scale (CARS).  Los Angeles, Calif Western Psychological Services1988;
60.
Bayley  N Bayley Scale of Infant Development. 2nd ed. San Antonio, Tex Psychological Corp1993;
61.
Mullen  E Mullen Scales of Early Learning.  Los Angeles, Calif Western Psychological Services1997;
62.
Elliot  C Differential Abilities Scale (DAS).  New York, NY Psychological Corp1990;
63.
Thorndike  RHagen  ESattler  J The Stanford-Binet Intelligence Scale: Guide for Administering and Scoring. 4th ed. Chicago, Ill Riverside Publishing Co1986;
64.
Wechsler  D Wechsler Intelligence Scale for Children. 4th ed. San Antonio, Tex Psychological Corp2003;
65.
Wechsler  D Wechsler Adult Intelligence Scale 3rd ed. San Antonio, Tex Psychological Corp1997;
66.
Roid  GMiller  L Leiter International Performance Scale-Revised.  Wood Dale, Ill Stoelting Co1997;
67.
Stutsman  R The Merrill-Palmer Scale of Mental Tests.  Chicago, Ill Stoelting Co1948;
68.
Sparrow  SBalla  DCicchetti  D Vineland Adaptive Behavior Scales, Expanded Edition.  Circle Pines, Minn American Guidance Service1984;
69.
Bruininks  RWoodcock  RWeatherman  RHill  B Scales of Independent Behavior–Revised (SIB-R).  Chicago, Ill Riverside Publishing Co1996;
70.
Shannon  MGraef  J Lead intoxication in children with pervasive developmental disorders  J Toxicol Clin Toxicol 1996;34177- 181PubMedArticle
71.
Gillberg  CColeman  M Autism and medical disorders: a review of the literature  Dev Med Child Neurol 1996;38191- 202PubMedArticle
72.
Challman  TDBarbaresi  WJKatusic  SKWeaver  A The yield of the medical evaluation of children with pervasive developmental disorders  J Autism Dev Disord 2003;33187- 192PubMedArticle
73.
Voigt  RGDickerson  CLReynolds  AMChilders  DORodriguez  DLBrown  FR Laboratory evaluation of children with autistic spectrum disorders: a guide for primary care pediatricians  Clin Pediatr (Phila) 2000;39669- 671PubMedArticle
74.
Shevell  MIMajnemer  ARosenbaum  PAbrahamowicz  M Etiologic yield of autistic spectrum disorder: a prospective study  J Child Neurol 2001;16509- 512PubMedArticle
75.
Chudley  AEGutierrez  EJocelyn  LJChodirker  BN Outcomes of genetic evaluation in children with pervasive developmental disorder  J Dev Behav Pediatr 1998;19321- 325PubMedArticle
76.
Kielinen  MRantala  HTimonen  ELinna  SLMoilanen  I Associated medical disorders and disabilities in children with autistic disorder: a population-based study  Autism 2004;849- 60PubMedArticle
77.
Kosinovsky  BHermon  SYoran-Hegesh  R  et al.  The yield of laboratory investigations in children with infantile autism  J Neural Transm 2005;112587- 596PubMedArticle
78.
Curatolo  PPorfirio  MCManzi  BSeri  S Autism in tuberous sclerosis  Eur J Paediatr Neurol 2004;8327- 332PubMedArticle
79.
Redcay  ECourchesne  E When is the brain enlarged in autism? a meta-analysis of all brain size reports  Biol Psychiatry 2005;581- 9PubMedArticle
80.
Boddaert  NZilbovicius  M Functional neuroimaging and childhood autism  Pediatr Radiol 2002;321- 7PubMedArticle
81.
Herbert  MRZiegler  DADeutsch  CK  et al.  Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis  Brain 2005;128213- 226PubMedArticle
82.
Rapin  I Autism  N Engl J Med 1997;33797- 104PubMedArticle
83.
Cohen  DPichard  NTordjman  S  et al.  Specific genetic disorders and autism: clinical contribution towards their identification  J Autism Dev Disord 2005;35103- 116PubMedArticle
84.
Muhle  RTrentacoste  SVRapin  I The genetics of autism  Pediatrics 2004;113e472- e486PubMedArticle
85.
Wassink  THBrzustowicz  LMBartlett  CWSzatmari  P The search for autism disease genes  Ment Retard Dev Disabil Res Rev 2004;10272- 283PubMedArticle
86.
Dykens  EMSutcliffe  JSLevitt  P Autism and 15Q11-Q13 disorders: behavioral, genetic, and pathophysiological issues  Ment Retard Dev Disabil Res Rev 2004;10284- 291PubMedArticle
87.
Carney  RMWolpert  CMRavan  SA  et al.  Identification of MeCP2 mutations in a series of females with autistic disorder  Pediatr Neurol 2003;28205- 211PubMedArticle
88.
Rutter  MBailey  ABolton  PLe Couteur  A Autism and known medical conditions: myth and substance  J Child Psychol Psychiatry 1994;35311- 322PubMedArticle
89.
Baieli  SPavone  LMeli  CFiumara  AColeman  M Autism and phenylketonuria  J Autism Dev Disord 2003;33201- 204PubMedArticle
90.
Gorker  ITuzun  U Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl  J Psychiatry Neurosci 2005;30133- 135PubMed
91.
Kohler  MAssmann  BBrautigam  C  et al.  Adenylosuccinase deficiency: possibly under diagnosed encephalopathy with variable clinical features  Eur J Paediatr Neurol 1999;33- 6PubMedArticle
92.
Tierney  ENwokoro  NAKelley  RI Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome  Ment Retard Dev Disabil Res Rev 2000;6131- 134PubMedArticle
93.
Oliveira  GDiogo  LGrazina  M  et al.  Mitochondrial dysfunction in autism spectrum disorders: a population-based study  Dev Med Child Neurol 2005;47185- 189PubMedArticle
94.
Tuchman  RRapin  I Epilepsy in autism  Lancet Neurol 2002;1352- 358PubMedArticle
95.
Olsson  ISteffenburg  SGillberg  C Epilepsy in autism and autistic-like conditions: a population-based study  Arch Neurol 1988;45666- 668PubMedArticle
96.
Tuchman  RFRapin  I Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates  Pediatrics 1997;99560- 566PubMedArticle
97.
Scott  RCNeville  BG Developmental perspectives on epilepsy  Curr Opin Neurol 1998;11115- 118PubMedArticle
98.
Nass  RPetrucha  D Acquired aphasia with convulsive disorder: a pervasive developmental disorder variant  J Child Neurol 1990;5327- 328PubMedArticle
99.
Lewine  JDAndrews  RChez  M  et al.  Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders  Pediatrics 1999;104405- 418PubMedArticle
100.
Rogers  SJ Empirically supported comprehensive treatments for young children with autism  J Clin Child Psychol 1998;27168- 179PubMedArticle
101.
Lovaas  OI Teaching Individuals With Developmental Delays: Basic Intervention Techniques.  Austin, Tex PRO-ED, Inc2003;
102.
Lovaas  OI Behavioral treatment and normal educational and intellectual functioning in young autistic children  J Consult Clin Psychol 1987;553- 9PubMedArticle
103.
McEachin  JJSmith  TLovaas  OI Long-term outcome for children with autism who received early intensive behavioral treatment  Am J Ment Retard 1993;97359- 372PubMed
104.
Schopler  EShort  AMesibov  G Relation of behavioral treatment to “normal functioning”: comment on Lovaas  J Consult Clin Psychol 1989;57162- 164PubMedArticle
105.
Smith  TEikeseth  SKlevstrand  MLovaas  O Intensive behavioral treatment for preschoolers with severe mental retardations and pervasive developmental disorder  Am J Ment Retard 1997;102238- 249PubMedArticle
106.
Sheinkopf  SJSiegel  B Home-based behavioral treatment of young children with autism  J Autism Dev Disord 1998;2815- 23PubMedArticle
107.
Eikeseth  SSmith  TJahr  EEldevik  S Intensive behavioral treatment at school for 4- to 7-year-old children with autism: a 1-year comparison controlled study  Behav Modif 2002;2649- 68PubMedArticle
108.
Howard  JSSparkman  CRCohen  HGGreen  GStanislaw  H A comparison of intensive behavior analytic and eclectic treatments for young children with autism  Res Dev Disabil 2005;26359- 383PubMedArticle
109.
Mesibov  GShea  VSchopler  E The TEACCH Approach to Autism Spectrum Disorders.  New York, NY Springer2005;
110.
Mesibov  G Formal and informal measures on the effectiveness of the TEACCH programme  Autism 1997;125- 35Article
111.
Mostert  MP Facilitated communication since 1995: a review of published studies  J Autism Dev Disord 2001;31287- 313PubMedArticle
112.
American Academy of Pediatrics, Committee on Children With Disabilities, Auditory integration training and facilitated communication for autism  Pediatrics 1998;102431- 433PubMedArticle
113.
Mudford  OCCross  BABreen  S  et al.  Auditory integration training for children with autism: no behavioral benefits detected  Am J Ment Retard 2000;105118- 129PubMedArticle
114.
Sinha  YSilove  NWheeler  DWilliams  K Auditory integration training and other sound therapies for autism spectrum disorders  Cochrane Database Syst Rev 2004; (1) CD003681PubMed
115.
Dawson  GWatling  R Interventions to facilitate auditory, visual, and motor integration in autism: a review of the evidence  J Autism Dev Disord 2000;30415- 421PubMedArticle
116.
Aman  MGNovotny  SSamango-Sprouse  C  et al.  Outcome measures for clinical drug trials in autism  CNS Spectr 2004;936- 47PubMed
117.
McCracken  JTMcGough  JShah  B  et al. Research Units on Pediatric Psychopharmacology Autism Network, Risperidone in children with autism and serious behavioral problems  N Engl J Med 2002;347314- 321PubMedArticle
118.
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network, Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity  Arch Gen Psychiatry 2005;621266- 1274PubMedArticle
119.
DeLong  GRTeague  LAMcSwain Kamran  M Effects of fluoxetine treatment in young children with idiopathic autism  Dev Med Child Neurol 1998;40551- 562PubMedArticle
120.
Jaselskis  CACook  EH  JrFletcher  KELeventhal  BL Clonidine treatment of hyperactive and impulsive children with autistic disorder  J Clin Psychopharmacol 1992;12322- 327PubMedArticle
121.
Steingard  RBiederman  J Lithium responsive manic-like symptoms in two individuals with autism and mental retardation  J Am Acad Child Adolesc Psychiatry 1987;26932- 935PubMedArticle
122.
American Academy of Pediatrics, Committee on Children With Disabilities, Technical report: the pediatrician's role in diagnosis and management of autistic spectrum disorder in children  Pediatrics 2001;1071221- 1226http://www.pediatrics.org/cgi/content/full/107/5/e85Accessed October 1, 2005Article
123.
Hyman  SLLevy  SE Autistic spectrum disorders: when traditional medicine is not enough  Contemp Pediatr 2000;17101- 116
124.
Kaptchuk  TJEisenberg  DM The persuasive appeal of alternative medicine  Ann Intern Med 1998;1291061- 1065PubMedArticle
125.
Bernard  SEnayati  ARedwood  LRoger  HBinstock  T Autism: a novel form of mercury poisoning  Med Hypotheses 2001;56462- 471PubMedArticle
126.
Aschner  MWalker  SJ The neuropathogenesis of mercury toxicity  Mol Psychiatry 2002;7(suppl 2)S40- S41PubMedArticle
127.
Hviid  AStellfeld  MWohlfahrt  JMelbye  M Association between thimerosal-containing vaccine and autism  JAMA 2003;2901763- 1766PubMedArticle
128.
Madsen  KMLauritsen  MBPedersen  CB  et al.  Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data  Pediatrics 2003;112604- 606PubMedArticle
129.
Levy  SEHyman  SL Novel treatments for autistic spectrum disorders  Ment Retard Dev Disabil Res Rev 2005;11131- 142PubMedArticle
130.
Dietrich  KNWare  HHSalganik  M  et al.  Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry  Pediatrics 2004;11419- 24PubMedArticle
131.
Wakefield  AJMurch  SHAnthony  A Ileal lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder  Lancet 1998;351637- 641PubMedArticle
132.
Dales  LHammer  SJSmith  NJ Time trends in autism and in MMR immunization coverage in California  JAMA 2001;2851183- 1185PubMedArticle
133.
Madsen  KMHviid  AVestergaard  M  et al.  A population-based study of measles, mumps, and rubella vaccination and autism  N Engl J Med 2002;3471477- 1482PubMedArticle
134.
Taylor  BLingam  RSimmons  AStowe  JMiller  EAndrews  N Autism and MMR vaccination in North London: no causal relationship  Mol Psychiatry 2002;7(suppl 2)S7- S8PubMedArticle
135.
Honda  HShimizu  YRutter  M No effect of MMR withdrawal on the incidence of autism: a total population study  J Child Psychol Psychiatry 2005;46572- 579PubMedArticle
136.
Paterson  R MMR debate fall-out continues  Lancet Infect Dis 2004;4653PubMedArticle
137.
Pavone  LFiumara  ABottaro  GMazzone  DColeman  M Autism and celiac disease: failure to validate the hypothesis that a link might exist  Biol Psychiatry 1997;4272- 75PubMedArticle
138.
Kuddo  TNelson  KB How common are gastrointestinal disorders in children with autism?  Curr Opin Pediatr 2003;15339- 343PubMedArticle
139.
Black  CKaye  JAJick  H Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database  BMJ 2002;325419- 421PubMedArticle
140.
Hunter  LCO'Hare  AHerron  WJFisher  LAJones  GE Opioid peptides and dipeptidyl peptidase in autism  Dev Med Child Neurol 2003;45121- 128PubMedArticle
141.
Williams  KMMarshall  T Urinary protein patterns in autism as revealed by high resolution two-dimensional electrophoresis  Biochem Soc Trans 1992;20189SPubMed
142.
Le Couteur  ATrygstad  OEvered  CGillberg  CRutter  M Infantile autism and urinary excretion of peptides and protein-associated peptide complexes  J Autism Dev Disord 1988;18181- 190PubMedArticle
143.
Horvath  KPapadimitriou  JCRabsztyn  ADrachenberg  CTildon  JT Gastrointestinal abnormalities in children with autistic disorder  J Pediatr 1999;135559- 563PubMedArticle
144.
DelGiudice-Asch  GSimon  LSchmeidler  JCunningham-Rundles  CHollander  E A pilot open clinical trial of intravenous immunoglobulin in childhood autism  J Autism Dev Disord 1999;29157- 160PubMedArticle
Review Article
November 2006

AutismA Review of the State of the Science for Pediatric Primary Health Care Clinicians

Author Affiliations

Author Affiliations: Departments of Pediatric and Adolescent Medicine, Division of Developmental and Behavioral Pediatrics (Drs Barbaresi and Voigt), and Health Sciences Research, Division of Epidemiology (Dr Katusic), and Mayo Clinic–Dana Child Development and Learning Disorders Program (Drs Barbaresi, Katusic, and Voigt), Mayo Clinic College of Medicine, Rochester, Minn.

Arch Pediatr Adolesc Med. 2006;160(11):1167-1175. doi:10.1001/archpedi.160.11.1167
Abstract

Autism is a complex neurodevelopmental disorder characterized by impaired reciprocal social interaction, impaired communication, and restricted, repetitive, or stereotyped behaviors. Autism seems to affect more children than was previously believed, although this phenomenon may be due to broadening of the diagnostic criteria and increased awareness of the condition. Recent research has clearly indicated the importance of early identification, since early intensive treatment is associated with better long-term outcome. There are many controversies and competing theories about the etiology and treatment of autism, often leaving families confused about the best course of treatment and intervention. Pediatric primary health care clinicians have an important role in both the early identification and ongoing management of children with autism. It is, therefore, essential that primary care clinicians have up-to-date information about the science of autism.

WHY A REVIEW ON AUTISM?

Autism and related conditions in the autism spectrum have become the focus of intense interest fueled by concerns about the apparent increase in the number of children with these developmental disorders.1,2 Pediatricians have an important role in the identification and ongoing management of children with autism. This article provides pediatric clinicians with a contemporary understanding of autism, including definitions, epidemiology, initial identification, formal diagnostic approaches, medical evaluation, treatment, controversies, and caregiver support.

WHAT IS AUTISM?

Autism, first described in 1943, is a complex developmental disorder characterized by severe impairment in reciprocal social interaction and communication and by a pattern of repetitive or stereotyped behavior.3,4 The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV, TR) includes autistic disorder in the broader category of pervasive developmental disorders, along with pervasive developmental disorder, not otherwise specified (PDD-NOS), Asperger's disorder, Rett's disorder, and childhood disintegrative disorder.3 Autistic disorder, PDD-NOS, and Asperger's disorder are often collectively referred to as the autism spectrum disorders (ASDs), while the term autism is used interchangeably with the DSM-IV, TR term autistic disorder. The term ASDs reflects the notion that these conditions are related and may be difficult to differentiate with current diagnostic tools.58 Pervasive developmental disorder, not otherwise specified is a somewhat ill-defined diagnosis of exclusion reserved for children with problems similar to those seen in autistic disorder but insufficient to meet the criteria for autistic disorder in number, severity, or age at onset.3,6,7

The diagnostic criteria for autism require the presence of 6 symptoms from 3 categories: impaired reciprocal social interaction (at least 2 symptoms), impaired communication, and restricted, repetitive, or stereotyped behaviors (Table 1). These criteria reflect the central role of deficits in social behavior in children with ASDs.3,9,10 One of the earliest and most important indicators of autism is the failure to develop joint attention,7,11,12 which refers to the child's ability to share interests, pleasurable experiences, or requests by using gestures or verbal communication in combination with eye contact with another person.

EPIDEMIOLOGY

There is widespread public concern about the apparent increase in autism, based on prevalence studies during the last 20 years.1,1317 Studies from the 1980s and early 1990s reported a prevalence of 4 to 10 per 10 000 children, whereas recent studies have reported prevalences of 30 to 50 per 10 000 children.1,1318 Studies that rely on administrative data for children who receive special education services have reported significant increases in prevalence from 1992 to 2001.19 A recent study in a single US county demonstrated an apparent increase in the incidence of research-identified autism among individuals 21 years of age or younger, from 5.5 per 100 000 in the 1980-1983 period to 44.9 per 100 000 in the 1995-1997 period.1 The advantage this incidence study had over previous prevalence studies was in its reporting rates of newly identified cases in the same community over many years with the use of consistent DSM-IV, TR–based research criteria for case identification. The timing of this apparent increase coincided with the introduction of broader diagnostic criteria, increased availability of educational services, and increased awareness of autism. These findings were not consistent with the hypotheses that immunization policy or the vaccine preservative thimerosal have contributed to this epidemiologic phenomenon.1,20 A recent review also noted the absence of published literature that demonstrates increased rates of autism in children who have been immunized with vaccines containing thimerosal.20 A study from the United Kingdom also concluded that the observed increase in the rate of diagnosis of pervasive developmental disorder is likely the result of better case ascertainment rather than a true increase in autism.21

IDENTIFICATION OF AUTISM BY PEDIATRIC PRIMARY HEALTH CARE CLINICIANS

Early identification of autism is important because early intervention services may be more effective in children with autism than in children with other developmental disabilities.22 Pediatric clinicians are ideally positioned to assume this role, aided by practice guidelines for the diagnosis and management of ASDs in children.7,23,24 A 2-level approach to autism screening and diagnosis is recommended.7 In children who fail routine developmental screening, specific screening for autism should be performed2528 (Table 2). In children who fail specific autism screening, referral for a formal evaluation by an experienced clinician is recommended. Referral is also recommended for any child who does not babble or point or use other gestures by the age of 12 months, who uses no single words by 16 months or no spontaneous (nonecholalic) 2-word phrases by 24 months, or who experiences any loss of any language or social skills at any age.7

Deficits in joint attention differentiate infants with autism from those with mental retardation or typical development.2932 These behaviors include deficits in the following areas: eye contact, orientation to name being called, pointing, and showing. In the toddler age group, a lack of pretend play and imitation, deficits in nonverbal communication, and disproportionate language delays differentiate autism from other developmental disorders.7 Although repetitive behaviors, stereotypic motor mannerisms, atypical sensory responses, and behavioral outbursts are generally observed in children with autism, these behaviors do not consistently differentiate autism from other developmental disorders at early ages.7

The Modified Checklist for Autism in Toddlers (M-CHAT) has been developed as an autism-specific screening tool for use in 24-month-old children (Table 2).3336 It consists of 23 items based on parental report, which makes this checklist efficient for use in primary care settings. Other promising screening instruments include the Pervasive Developmental Disorders Screening Test–II37 and the Screening Tool for Autism in Two-Year Olds.38 For children who are 4 years or older, the Social Communication Questionnaire may be used as an autism screening instrument.7,27,28

Children with autism can also be identified by a characteristic early developmental profile, with relative strengths in visuomotor problem solving and discrepant and disproportionate weaknesses in language.3950 The Cognitive Adaptive Test/Clinical Linguistic and Auditory Milestone Scale (Capute Scales) provides quantitative information about a child's development in the domains of language and visuomotor problem solving and can be used efficiently for this purpose in primary care settings.51

DIAGNOSING AUTISM

A comprehensive, multidisciplinary assessment is required to evaluate a child for an ASD and to differentiate ASDs from other developmental disorders.57,12,52 Since there are no definitive diagnostic tests, a clinical diagnosis by an expert, based on DSM-IV, TR criteria, remains the gold standard of ASD diagnosis.6,7,12,52 The DSM-IV, TR criteria consist of a list of behaviors that are not described in detail, leaving considerable latitude for clinical judgment.3,7,12 Children who have been evaluated exclusively by school or early intervention staff should not be considered to have undergone a thorough diagnostic assessment. This can be confusing to both parents and pediatricians, given the existence of the explicit special education category “Autism Spectrum Disorders” (Individuals with Disabilities Education Act [IDEA] 97, Pub L No. 105-17).53 An ASD designation for special education purposes may be obtained without a clinical diagnosis of an ASD. Furthermore, children with autism or PDD-NOS often have severe cognitive, communicative, and behavioral problems that can only be assessed by a team of professionals (Table 3). The clinical diagnosis of an ASD is facilitated by the use of rating scales and direct assessment tools specifically developed for this purpose (Table 4).5459

Approximately 60% to 75% of children with autistic disorder or PDD-NOS have cognitive skills in the mentally retarded range (standard scores <70 on formal cognitive tests).1,3 Fewer children with PDD-NOS are likely to function in the mentally retarded range.52 Children with autism or PDD-NOS often demonstrate relative strength in visual problem-solving skills and relative weakness in language-based cognitive skills; this discrepant cognitive profile may be reflected in a significant discrepancy between verbal and performance IQ scores.3,7,3950,52 Formal cognitive assessment should be completed using instruments that have been demonstrated to be appropriate6067 (Table 5).

Similarly, formal speech and language assessment is essential because communication deficits of varying severity are always present in children with ASD.3,7,12 Children with ASD may have specific deficits in the social use of language, often referred to as pragmatic language.3,7,12 For example, a child may be able to recite long segments of dialogue from a favorite video yet not be able to use a 3-word sentence to ask for something to eat. Problems with pragmatic language are often identified only by a careful history or direct observation of the child in his or her natural environment.3,7,12

Social-adaptive behavioral assessments should include assessment of functional skills such as sleeping, eating, and toileting and problem behaviors such as aggression, oppositionality, and self-injury. This assessment is facilitated by the use of formal questionnaires and rating scales including, among others, the Vineland Adaptive Behavior Scales and the Scales of Independent Behavior.68,69 Formal assessments of fine and gross motor skills may be incorporated into the evaluation as indicated. Parent resources should be carefully assessed to enable the team to understand the context of the child's developmental problems and to ensure that plans are made to provide appropriate support to the family.

MEDICAL EVALUATION OF CHILDREN WITH AUTISM

Every child with autism should undergo a formal audiologic evaluation, whether or not the child passed a newborn hearing screening test. In addition, children with autism are at risk of lead toxicity, given their high prevalence of putting objects in their mouths.70 Thus, periodic lead screening should be performed until pica resolves.7

Although a recognizable etiologic disorder is found in fewer than 25% of individuals with autism, attempts to establish an etiologic diagnosis to account for this clinical syndrome are important to identify diagnoses that may affect prognosis, risk of recurrence, and associated medical morbidity. A thorough history and physical examination should guide the medical diagnostic workup7177 (Table 6). Since tuberous sclerosis accounts for up to 3% to 4% of autism cases, Wood's lamp examinations should be performed in every child with autism to detect the hypopigmented macules associated with this syndrome, especially if the child has an intercurrent seizure disorder.78 While routine head imaging (computed tomography or magnetic resonance imaging) is not recommended, recent studies have reported abnormal patterns of brain growth in individuals with autism.79 Functional imaging techniques are currently used as research tools but are not indicated in routine clinical practice.7,80,81

Autism has been associated with many genetic syndromes, including Down syndrome, Angelman syndrome, de Lange syndrome, Smith-Magenis syndrome, and Smith-Lemli-Opitz syndrome.82,83 Seven percent to 8% of individuals with autism have fragile X syndrome.84 In addition, anomalies in almost every chromosome have been reported in individuals with autism, although more consistent linkage findings have been associated with chromosomes 2q, 7q, and 15q.85 Thus, DNA testing for fragile X syndrome and high-resolution chromosome analyses are recommended in the laboratory workup in children with autism, especially those with mental retardation, dysmorphic features, congenital anomalies, or a family history of autism or mental retardation.7,84 Fluorescent in situ hybridization testing for specific chromosome deletions, duplications, or inversions should be considered if initial investigations produce negative results8487 (Table 6). Even in the absence of a specific genetic diagnosis, the recurrence rate in siblings of children with autism is between 2% and 8%, increasing the risk of having a second child with autism nearly 50-fold over that in the general population.84

Although a wide range of inborn errors of metabolism have been associated with autistic behavior, less than 5% of children with autism have identifiable metabolic disorders.8893 Thus, metabolic testing is particularly indicated when the autistic behaviors are accompanied by a history of developmental plateauing or regression; decompensation with mild illness, unusual odors, or food intolerance; failure to thrive; episodic lethargy; cyclic vomiting; seizures; coarse features; mental retardation; questionable newborn screening results; or birth outside the United States7 (Table 6).

By adulthood, about one third of individuals with autism will have at least 2 unprovoked epileptic seizures.82 Onset of seizures in individuals with autism follows a bimodal age distribution, with peaks in early childhood and adolescence.7,94 All seizure types, including infantile spasms, can be associated with autism, but partial complex seizures, with electroencephalographic abnormalities occurring most often over the temporal lobes, appear to be most prevalent.95 About one third of parents of children with autism report regression of language in their children, most commonly the loss of their toddler's first few words, between age 18 and 24 months.94,96 Approximately 10% of children with autism also have a paroxysmal electroencephalographic pattern similar to that seen in Landau-Kleffner syndrome (acquired epileptic aphasia) or electrical status epilepticus during slow-wave sleep.94 While there have been reports of the use of anticonvulsant therapy and even epilepsy surgery, there is insufficient evidence to recommend routine electroencephalography in all children with autism.9799 Indications for prolonged sleep-deprived electroencephalography with adequate sampling of slow-wave sleep are listed in Table 6.7

EDUCATIONAL AND BEHAVIORAL INTERVENTIONS

Pediatricians have an important role in helping to guide families toward intervention approaches that have been empirically demonstrated as effective.5,52,100 In the Internet era, families have access to virtually limitless information about treatments and interventions for autism. Since family resources of time, energy, and finances are limited, it is essential to ensure that these resources are directed toward interventions that offer the best hope for improved outcome.

The Individuals with Disabilities Education Act mandates educational services for children in the special education category of Autism Spectrum Disorders.52 The provisions of the Individuals with Disabilities Education Act do not, however, ensure that children will receive empirically validated interventions of appropriate intensity. There is, therefore, considerable variability in the quality of educational interventions for children with ASD. This is an additional important reason for pediatricians to understand and advocate for optimal services.

Decades-worth of scientific research provide clear and convincing support for the technique referred to as Applied Behavior Analysis (ABA).5,100 This technique uses the principles of operant conditioning to teach specific social, communicative, and behavioral skills to children with ASD.5,100 It involves teaching new behaviors by explicit reinforcement of these behaviors; problem behaviors are often addressed by carefully analyzing triggers or antecedents of the problem behavior in order to change the factors in the environment that are contributing to the problem behavior. Applied Behavior Analysis also uses careful collection of data to demonstrate the efficacy of treatment in the individual child; the data are used to assess progress and to continually modify the intervention as the child progresses toward specific learning objectives.101

Interest in ABA as a primary, comprehensive treatment approach in children with ASD was sparked by the research of Lovaas,102,103 who reported that 9 (47%) of 19 young children with autism who received intensive, early ABA (40 hours per week for ≥2 years) had outcomes that were indistinguishable from their normally developing peers.103 Subsequent studies have led many experts in the field to conclude that intensive ABA is an effective intervention but that it is unlikely that 50% of children who receive early, intensive ABA will achieve completely normal developmental outcomes.100,104107 Practice guidelines have used these and other research findings to formulate recommendations on the key features of appropriate intervention for children with autism.5,52,100 Characteristics of effective intervention are believed to include a minimum of 20 hours per week of carefully organized services initiated at an early age (preferably younger than 4 years) and involving direct adult attention in individual or very small group instruction.5,7,52,100 Recent studies have concluded that intensity of intervention is important (ie, a minimum of 20 hours per week) and that ABA is superior to other intervention strategies.100,108

Another intervention model with a long history and well-defined instructional methods is TEACCH (Treatment and Education of Autistic and Related Communication Handicapped Children).109 The TEACCH approach takes advantage of relative strengths in visual information processing, characteristic of many children with ASD, using strategies such as visual schedules, clearly structured and organized classrooms, and highly structured learning activities that are broken down into manageable, visually organized steps. Published reports demonstrate improvement in behaviors and functional skills and parent satisfaction with the TEACCH approach.52,109,110 However, there appear to be no direct studies of treatment outcomes attributable to TEACCH interventions.

While other intervention strategies are often recommended, there do not appear to be approaches that have the empirical support of ABA or the long history and well-developed curricula of TEACCH. The weight of currently available scientific evidence, however, indicates that ABA should be viewed as the optimal, comprehensive treatment approach in young children with ASD.

Pediatricians should also be aware of sensory integration therapy because this approach is often used in special education programs. Interest in sensory integration is related to the observation that children with ASD often exhibit unusual sensory responses, such as hypersensitivity to certain noises. Techniques used in this therapy include “brushing” of the skin, “swinging” to stimulate vestibular responses, and deep-pressure massage applied in an effort to calm the child.52 There is no available empirical support for sensory integration therapy, and it should, therefore, neither be routinely recommended nor viewed as a primary intervention strategy in children with ASD.5,52

Many other unproved nonmedical therapies have been recommended for use in children with autism. There is no evidence to support the use of facilitated communication, auditory integration training, or music therapy.5,111115

MEDICAL INTERVENTIONS FOR CHILDREN WITH AUTISM

Although psychopharmacologic therapies have been studied for more than 50 years, there are no Food and Drug Administration–approved indications for the treatment of autism with any agent and there is no medication available for treatment of the core deficits in communication and social interaction.116 In addition, when used to treat similar target behaviors, psychotropic medications tend to be less effective and result in more adverse effects when used in children with autism compared with children without autism because of similar target behavioral symptoms. However, there is an evidence base for prescribing risperidone to assist in managing tantrums, aggression, and self-injurious and stereotypic behaviors and for prescribing methylphenidate to manage inattentive, impulsive, and hyperactive behaviors in children with autism.117,118 To date, there is insufficient evidence to support the use of selective serotonin reuptake inhibitors, α2-adrenergic agonists, or mood stabilizers, despite reports of their effectiveness in managing target behavioral symptoms in some children with autism in short-term open-label trials with small sample sizes.119121 Psychotropic medications should never be used in isolation but used only in conjunction with behavioral, educational, and habilitative therapies.122 If psychotropic medications are used, initial dosage should be low, with gradual increases in dosage until optimal positive effects, without significant adverse effects, are achieved.

UNPROVED THEORIES OF CAUSATION AND UNPROVED OR INEFFECTIVE TREATMENTS IN CHILDREN WITH AUTISM

Traditional medicine does not offer a cure for autism. As a result, unproved complementary and alternative treatments are often provided to children with autism by parents who are seeking effective biomedical interventions.123 Patients with chronic conditions with unclear pathophysiologic features, fluctuating courses, highly subjective symptoms, and few effective evidence-based treatments are most vulnerable to the placebo effect.124 Such is clearly the case in autism, and unproved explanations of causation and unproved therapies abound.

One example is the controversy about whether the mercury-containing compound thimerosal, which has been included in certain vaccines to protect multiple-dose vials from bacterial and fungal contamination, is related to the increased prevalence of autism.125 However, no children with autism have been reported to have an abnormal body burden of mercury or an excess of mercury in hair, urine, or blood.126 Neither the clinical signs and symptoms of mercury-induced neurologic damage nor the neuropathologic changes associated with mercury exposure parallel the clinical signs and symptoms of autism.20 Population-based studies have also shown that the risk of autism in children given thimerosal-containing vaccines is no different from that in children given thimerosal-free vaccines.20,127 Further, since thimerosal was removed from childhood vaccines in Denmark in 1992, the incidence of autism in that country has continued to rise.128 Despite this overwhelming scientific evidence, some children with autism are receiving treatment with chelating agents.129 However, even if exposure to mercury or other heavy metals was causative of autism, chelation therapy has not been found to improve the neurodevelopmental sequelae of heavy metal toxicity.130 Also, children being treated with chelating agents are at risk of renal and hepatic toxic adverse effects.129

There have been concerns about the potential role of the measles-mumps-rubella (MMR) vaccine in the causation of autism, based on findings that have been partially retracted.131 This theory hypothesizes that the MMR vaccine produces enterocolitis, causing “leaky gut,” which then leads to increased absorption of peptides with bioactive properties of endogenous opioids that produce the symptoms of autism.123 However, large-scale epidemiologic studies have failed to show an association between the MMR vaccine and autism.1,132135 Furthermore, a dramatically increased incidence of autism has been associated with the withdrawal of the MMR vaccine in Japan.135 Despite strong evidence against an association between either thimerosal or MMR vaccines and autism, fear generated by these scientifically disproved theories may be leading more parents to decline to have their children immunized.136

The leaky gut hypothesis has also led to unproved claims that variants of celiac disease, yeast overgrowth, and immunologic abnormalities can cause autism.123,129 Many children with autism have been given very restrictive gluten- and casein-free diets because of unfounded fears that opioidlike peptides derived from gluten and casein are absorbed through their leaky guts and can be detected in their urine. However, children with autism have not been found to have an increased rate of celiac disease and do not have excessive amounts of opioidlike compounds in their urine.137142

Although hypothesized as another cause of leaky gut, fungal overgrowth in the intestines has not been documented at endoscopy in children with autism.143 While there is no evidence that systemic antifungal medications improve autistic behavior, these medications are associated with liver toxicity, anemia, diarrhea, and exfoliative dermatitis.123,129

It has been hypothesized that autism is an autoimmune disorder; however, treatment with intravenous immunoglobulin has not proved effective.144 The pancreatic hormone secretin has also been proposed as a treatment of autism. However, more than a dozen published, peer-reviewed, randomized, double-blind, placebo-controlled trials have failed to show secretin to be effective in treating the symptoms of autism.129 Other medical therapies that have been recommended but that do not have sufficient evidence to support their effectiveness or safety include vitamin and mineral supplements (vitamin B6 and magnesium, vitamin C, vitamin B12, and folic acid), amino acid and peptide supplements (dimethyl glycine and carnosine), and ω-3 long-chain polyunsaturated fatty acids.129

Clinicians should counsel parents of children with autism to be sure that any treatment they may consider is supported by evidence from randomized, double-blind, placebo-controlled clinical trials published in the peer-reviewed medical literature. Families should be informed about potential health risks associated with unproved therapies. Finally, parents should be reminded that such treatments may take time, effort, and financial resources away from effective, evidence-based interventions.

FAMILY AND CAREGIVER SUPPORT

Families that include a child with one of the ASDs experience considerable stress as they are confronted with extraordinary demands on their time, energy, and financial resources. It is essential to offer clear explanations of diagnostic findings and treatment recommendations and to guide families toward effective treatment approaches. This requires the combined effort of experts in the ASD field working collaboratively with primary care clinicians.

Parents need reliable sources of information about ASDs. This is particularly important in an era when the Internet makes misinformation as easily available as accurate information. The Web sites sponsored by the Autism Society of America (www.autism-society.org/site/PageServer), TEACCH (www.teacch.com), and the National Institute of Child Health and Human Development (www.nichd.nih.gov/publications/pubs/autismfacts.pdf) are particularly useful sources of reliable information. However, even accurate information about ASDs is subject to misinterpretation because of the inherent complexity of the topic and the many unanswered questions in the field. There is no substitute for knowledgeable professionals who provide ongoing advice in the context of regular primary care management of children with ASDs.

Correspondence: William J. Barbaresi, MD, Departments of Pediatric and Adolescent Medicine, Division of Developmental and Behavioral Pediatrics, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905 (barbaresi.william@mayo.edu).

Accepted for Publication: May 5, 2006.

Author Contributions:Study concept and design: Barbaresi, Katusic, and Voigt. Drafting of the manuscript: Barbaresi, Katusic, and Voigt. Critical revision of the manuscript for important intellectual content: Barbaresi, Katusic, and Voigt. Administrative, technical, and material support: Barbaresi, Katusic, and Voigt. Study supervision: Barbaresi.

Financial Disclosure: None reported.

References
1.
Barbaresi  WJKatusic  SKColligan  RCWeaver  ALJacobsen  SJ The incidence of autism in Olmsted County, Minnesota, 1976-1997: results from a population-based study  Arch Pediatr Adolesc Med 2005;15937- 44PubMedArticle
2.
Stratton  KedGable  AedShetty  PedMcCormich  Med Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism.  Washington, DC National Academy Press2001;
3.
American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision.  Washington, DC American Psychiatric Association2000;
4.
Kanner  L Autistic disturbances of affective contact  Nervous Child 1943;2217- 250
5.
New York State Department of Health Early Intervention Program, Clinical Practice Guideline: Report of the Recommendations, Autism/Pervasive Developmental Disorders.  Albany New York State Dept of Health, Health Education Services1999;
6.
Lord  CRisi  S Frameworks and methods in diagnosing autism spectrum disorders  Ment Retard Dev Disabil Res Rev 1998;490- 96Article
7.
Filipek  PAAccardo  PJBaranek  GT  et al.  The screening and diagnosis of autistic spectrum disorders [published correction appears in J Autism Dev Disord. 2000;30:81]  J Autism Dev Disord 1999;29439- 484PubMedArticle
8.
Lord  CVolkmar  F Genetics of childhood disorders, XLII: autism, part 1: diagnosis and assessment in autistic spectrum disorders  J Am Acad Child Adolesc Psychiatry 2002;411134- 1136PubMedArticle
9.
Wing  LGould  J Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification  J Autism Dev Disord 1979;911- 29PubMedArticle
10.
Beglinger  LSmith  T Concurrent validity of social subtype and IQ after early intensive behavioral intervention in children with autism: a preliminary investigation  J Autism Dev Disord 2005;35295- 303PubMedArticle
11.
Volkmar  FChawarska  KKlin  A Autism in infancy and early childhood  Annu Rev Psychol 2005;56315- 336PubMedArticle
12.
Volkmar  FRLord  CBailey  ASchultz  RTKlin  A Autism and pervasive developmental disorders  J Child Psychol Psychiatry 2004;45135- 170PubMedArticle
13.
Wing  LPotter  D The epidemiology of autistic spectrum disorders: is the prevalence rising?  Ment Retard Dev Disabil Res Rev 2002;8151- 161PubMedArticle
14.
Fombonne  ESimmons  HFord  TMeltzer  HGoodman  R Prevalence of pervasive developmental disorder in the British nationwide survey of child mental health  J Am Acad Child Adolesc Psychiatry 2001;40820- 827PubMedArticle
15.
Fombonne  E The prevalence of autism  JAMA 2003;28987- 89PubMedArticle
16.
Yeargin-Allsopp  MRice  CKarapurkar  TDoernberg  NBoyle  CMurphy  C Prevalence of autism in a US metropolitan area  JAMA 2003;28949- 55PubMedArticle
17.
Bertrand  JMars  ABoyle  CBove  FYeargin-Allsopp  MDecoufle  P Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation  Pediatrics 2001;1081155- 1161PubMedArticle
18.
Gernsbacher  MDawson  MGoldsmith  H Three reasons not to believe in an autism epidemic  Curr Dir Psychol Sci 2005;1455- 58Article
19.
Newschaffer  CJFalb  MDGurney  JG National autism prevalence trends from United States special education data  Pediatrics 2005;115e277- e282PubMedArticle
20.
Nelson  KBBauman  ML Thimerosal and autism?  Pediatrics 2003;111674- 679PubMedArticle
21.
Smeeth  LCook  CFombonne  PE  et al.  Rate of first recorded diagnosis of autism and other pervasive developmental disorders in United Kingdom general practice, 1988 to 2001  BMC Med 2004;239PubMedArticle
22.
Lipkin  PHSchertz  MCapute  AJedAccardo  PJed An assessment of the efficacy of early intervention programs  Developmental Disabilities in Infancy and Childhood. 2nd ed. Baltimore, Md Brookes Publishing Co1996;525- 547
23.
American Academy of Pediatrics,; Council on Children with Disabilities, Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening  Pediatrics 2006;118405- 420PubMedArticle
24.
American Academy of Pediatrics, Committee on Children with Disabilities, The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children  Pediatrics 2001;1071221- 1226PubMedArticle
25.
Baron-Cohen  SAllen  JGillberg  C Can autism be detected at 18 months? the needle, the haystack, and the CHAT  Br J Psychiatry 1992;161839- 843PubMedArticle
26.
Baron-Cohen  SWheelwright  SCox  A  et al.  Early identification of autism by the CHecklist for Autism in Toddlers (CHAT)  J R Soc Med 2000;93521- 525PubMed
27.
Berument  SKRutter  MLord  CPickles  ABailey  A Autism screening questionnaire: diagnostic validity  Br J Psychiatry 1999;175444- 451PubMedArticle
28.
Rutter  MBailey  ALord  C SCQ: Social Communication Questionnaire.  Los Angeles, Calif Western Psychological Services2003;
29.
Osterling  JDawson  G Early recognition of children with autism: a study of first birthday home videotapes  J Autism Dev Disord 1994;24247- 257PubMedArticle
30.
Mars  AEMauk  JEDowrick  P Symptoms of pervasive developmental disorders as observed in prediagnostic home videos of infants and toddlers  J Pediatr 1998;132500- 504PubMedArticle
31.
Werner  EDawson  GOsterling  JDinno  N Brief report: recognition of autism spectrum disorder before one year of age: a retrospective study based on home videotapes  J Autism Dev Disord 2000;30157- 162PubMedArticle
32.
Baranek  GT Autism during infancy: a retrospective video analysis of sensory-motor and social behaviors at 9-12 months of age  J Autism Dev Disord 1999;29213- 224PubMedArticle
33.
Baird  GCharman  TBaron-Cohen  S  et al.  A screening instrument for autism at 18 months of age: a 6-year follow-up study  J Am Acad Child Adolesc Psychiatry 2000;39694- 702PubMedArticle
34.
Chouieri  RBridgemohan  C To make the biggest difference, screen early for autism spectrum disorders  Contemp Pediatr 2005;2254- 64
35.
Robins  DLFein  DBarton  MLGreen  JA The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders  J Autism Dev Disord 2001;31131- 144PubMedArticle
36.
Dumont-Mathieu  TFein  D Screening for autism in young children: the Modified Checklist for Autism in Toddlers (M-CHAT) and other measures  Ment Retard Dev Disabil Res Rev 2005;11253- 262PubMedArticle
37.
Siegel  B Pervasive Developmental Disorders Screening Test—II.  San Antonio, Tex Harcourt Assessment Inc2004;
38.
Stone  WLCoonrod  EETurner  LMPozdol  SL Psychometric properties of the STAT for early autism screening  J Autism Dev Disord 2004;34691- 701PubMedArticle
39.
Lockyer  LRutter  M A five- to fifteen-year follow-up study of infantile psychosis, IV: Patterns of cognitive ability  Br J Soc Clin Psychol 1970;9152- 163PubMedArticle
40.
Happe  FGE Wechsler IQ profile and theory of mind in autism: a research note  J Child Psychol Psychiatry 1994;351461- 1471PubMedArticle
41.
Dennis  MLockyer  LLazenby  ALDonnelly  REWilkinson  MSchoonheyt  W Intelligence patterns among children with high-functioning autism, phenylketonuria, and childhood head injury  J Autism Dev Disord 1999;295- 17PubMedArticle
42.
Joseph  RMTager-Flusberg  HLord  C Cognitive profiles and social-communicative functioning in children with autism spectrum disorder  J Child Psychol Psychiatry 2002;43807- 821PubMedArticle
43.
Ehlers  SNyden  AGillberg  C  et al.  Asperger syndrome, autism, and attention disorders: a comparative study of the cognitive profiles of 120 children  J Child Psychol Psychiatry 1997;38207- 217PubMedArticle
44.
Klin  AVolkmar  FRSparrow  SSCicchetti  DVRourke  BP Validity and neuropsychological characterization of Asperger syndrome: convergence with nonverbal learning disabilities syndrome  J Child Psychol Psychiatry 1995;361127- 1140PubMedArticle
45.
Mayes  SDCalhoun  SL Similarities and differences in Wechsler intelligence Scale for Children, third edition (WISC-III) profiles: support for subtest analysis in clinical referrals  Clin Neuropsychol 2004;18559- 572PubMedArticle
46.
Mayes  SDCalhoun  SL Ability profiles in children with autism: influence of age and IQ  Autism 2003;765- 80PubMedArticle
47.
Mayes  SDCalhoun  SL Analysis of WISC-II, Stanford–Binet IV, and academic achievement test scores in children with autism  J Autism Dev Disord 2003;33329- 341PubMedArticle
48.
Shah  AFrith  U Why do autistic individuals show superior performance on the block design task?  J Child Psychol Psychiatry 1993;341351- 1364PubMedArticle
49.
Voigt  RGChilders  DODickerson  CL  et al.  Early pediatric neurodevelopmental profile of children with autistic spectrum disorders  Clin Pediatr (Phila) 2000;39663- 668PubMedArticle
50.
Voigt  RGAccardo  PJedCapute  AJed The Capute Scales in research  The Capute Scales. Baltimore, Md Brookes Publishing Co2005;41- 46
51.
Accardo  PJedCapute  AJed The Capute Scales.  Baltimore, Md Brookes Publishing Co2005;
52.
Lord C, McGee JP, eds, for the Committee on Educational Interventions for Children with Autism, Division of Behavioral and Social Sciences and Education, National Research Council, Educating Children With Autism.  Washington, DC National Academy Press2001;
53.
Individuals with Education Disabilities Act,,Public Law 105-117 (1997)
54.
Lord  CRutter  MLe Couteur  A Autism Diagnostic Interview–Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders  J Autism Dev Disord 1994;24659- 685PubMedArticle
55.
Klinger  LGRenner  P Performance-based measures in autism: implications for diagnosis, early detection, and identification of cognitive profiles  J Clin Child Psychol 2000;29479- 492PubMedArticle
56.
Lord  CPickles  AMcLennan  J  et al.  Diagnosing autism: analyses of data from the Autism Diagnostic Interview  J Autism Dev Disord 1997;27501- 517PubMedArticle
57.
Lord  CRisi  SLambrecht  L  et al.  The Autism Diagnostic Observation Schedule–Generic: a standard measure of social and communication deficits associated with the spectrum of autism  J Autism Dev Disord 2000;30205- 223PubMedArticle
58.
Gilliam  J Gilliam Autism Rating Scale (GARS).  Austin, Tex PRO-ED, Inc1995;
59.
Schopler  EReichler  RRochen-Renner  B The Childhood Autism Rating Scale (CARS).  Los Angeles, Calif Western Psychological Services1988;
60.
Bayley  N Bayley Scale of Infant Development. 2nd ed. San Antonio, Tex Psychological Corp1993;
61.
Mullen  E Mullen Scales of Early Learning.  Los Angeles, Calif Western Psychological Services1997;
62.
Elliot  C Differential Abilities Scale (DAS).  New York, NY Psychological Corp1990;
63.
Thorndike  RHagen  ESattler  J The Stanford-Binet Intelligence Scale: Guide for Administering and Scoring. 4th ed. Chicago, Ill Riverside Publishing Co1986;
64.
Wechsler  D Wechsler Intelligence Scale for Children. 4th ed. San Antonio, Tex Psychological Corp2003;
65.
Wechsler  D Wechsler Adult Intelligence Scale 3rd ed. San Antonio, Tex Psychological Corp1997;
66.
Roid  GMiller  L Leiter International Performance Scale-Revised.  Wood Dale, Ill Stoelting Co1997;
67.
Stutsman  R The Merrill-Palmer Scale of Mental Tests.  Chicago, Ill Stoelting Co1948;
68.
Sparrow  SBalla  DCicchetti  D Vineland Adaptive Behavior Scales, Expanded Edition.  Circle Pines, Minn American Guidance Service1984;
69.
Bruininks  RWoodcock  RWeatherman  RHill  B Scales of Independent Behavior–Revised (SIB-R).  Chicago, Ill Riverside Publishing Co1996;
70.
Shannon  MGraef  J Lead intoxication in children with pervasive developmental disorders  J Toxicol Clin Toxicol 1996;34177- 181PubMedArticle
71.
Gillberg  CColeman  M Autism and medical disorders: a review of the literature  Dev Med Child Neurol 1996;38191- 202PubMedArticle
72.
Challman  TDBarbaresi  WJKatusic  SKWeaver  A The yield of the medical evaluation of children with pervasive developmental disorders  J Autism Dev Disord 2003;33187- 192PubMedArticle
73.
Voigt  RGDickerson  CLReynolds  AMChilders  DORodriguez  DLBrown  FR Laboratory evaluation of children with autistic spectrum disorders: a guide for primary care pediatricians  Clin Pediatr (Phila) 2000;39669- 671PubMedArticle
74.
Shevell  MIMajnemer  ARosenbaum  PAbrahamowicz  M Etiologic yield of autistic spectrum disorder: a prospective study  J Child Neurol 2001;16509- 512PubMedArticle
75.
Chudley  AEGutierrez  EJocelyn  LJChodirker  BN Outcomes of genetic evaluation in children with pervasive developmental disorder  J Dev Behav Pediatr 1998;19321- 325PubMedArticle
76.
Kielinen  MRantala  HTimonen  ELinna  SLMoilanen  I Associated medical disorders and disabilities in children with autistic disorder: a population-based study  Autism 2004;849- 60PubMedArticle
77.
Kosinovsky  BHermon  SYoran-Hegesh  R  et al.  The yield of laboratory investigations in children with infantile autism  J Neural Transm 2005;112587- 596PubMedArticle
78.
Curatolo  PPorfirio  MCManzi  BSeri  S Autism in tuberous sclerosis  Eur J Paediatr Neurol 2004;8327- 332PubMedArticle
79.
Redcay  ECourchesne  E When is the brain enlarged in autism? a meta-analysis of all brain size reports  Biol Psychiatry 2005;581- 9PubMedArticle
80.
Boddaert  NZilbovicius  M Functional neuroimaging and childhood autism  Pediatr Radiol 2002;321- 7PubMedArticle
81.
Herbert  MRZiegler  DADeutsch  CK  et al.  Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis  Brain 2005;128213- 226PubMedArticle
82.
Rapin  I Autism  N Engl J Med 1997;33797- 104PubMedArticle
83.
Cohen  DPichard  NTordjman  S  et al.  Specific genetic disorders and autism: clinical contribution towards their identification  J Autism Dev Disord 2005;35103- 116PubMedArticle
84.
Muhle  RTrentacoste  SVRapin  I The genetics of autism  Pediatrics 2004;113e472- e486PubMedArticle
85.
Wassink  THBrzustowicz  LMBartlett  CWSzatmari  P The search for autism disease genes  Ment Retard Dev Disabil Res Rev 2004;10272- 283PubMedArticle
86.
Dykens  EMSutcliffe  JSLevitt  P Autism and 15Q11-Q13 disorders: behavioral, genetic, and pathophysiological issues  Ment Retard Dev Disabil Res Rev 2004;10284- 291PubMedArticle
87.
Carney  RMWolpert  CMRavan  SA  et al.  Identification of MeCP2 mutations in a series of females with autistic disorder  Pediatr Neurol 2003;28205- 211PubMedArticle
88.
Rutter  MBailey  ABolton  PLe Couteur  A Autism and known medical conditions: myth and substance  J Child Psychol Psychiatry 1994;35311- 322PubMedArticle
89.
Baieli  SPavone  LMeli  CFiumara  AColeman  M Autism and phenylketonuria  J Autism Dev Disord 2003;33201- 204PubMedArticle
90.
Gorker  ITuzun  U Autistic-like findings associated with a urea cycle disorder in a 4-year-old girl  J Psychiatry Neurosci 2005;30133- 135PubMed
91.
Kohler  MAssmann  BBrautigam  C  et al.  Adenylosuccinase deficiency: possibly under diagnosed encephalopathy with variable clinical features  Eur J Paediatr Neurol 1999;33- 6PubMedArticle
92.
Tierney  ENwokoro  NAKelley  RI Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome  Ment Retard Dev Disabil Res Rev 2000;6131- 134PubMedArticle
93.
Oliveira  GDiogo  LGrazina  M  et al.  Mitochondrial dysfunction in autism spectrum disorders: a population-based study  Dev Med Child Neurol 2005;47185- 189PubMedArticle
94.
Tuchman  RRapin  I Epilepsy in autism  Lancet Neurol 2002;1352- 358PubMedArticle
95.
Olsson  ISteffenburg  SGillberg  C Epilepsy in autism and autistic-like conditions: a population-based study  Arch Neurol 1988;45666- 668PubMedArticle
96.
Tuchman  RFRapin  I Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates  Pediatrics 1997;99560- 566PubMedArticle
97.
Scott  RCNeville  BG Developmental perspectives on epilepsy  Curr Opin Neurol 1998;11115- 118PubMedArticle
98.
Nass  RPetrucha  D Acquired aphasia with convulsive disorder: a pervasive developmental disorder variant  J Child Neurol 1990;5327- 328PubMedArticle
99.
Lewine  JDAndrews  RChez  M  et al.  Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders  Pediatrics 1999;104405- 418PubMedArticle
100.
Rogers  SJ Empirically supported comprehensive treatments for young children with autism  J Clin Child Psychol 1998;27168- 179PubMedArticle
101.
Lovaas  OI Teaching Individuals With Developmental Delays: Basic Intervention Techniques.  Austin, Tex PRO-ED, Inc2003;
102.
Lovaas  OI Behavioral treatment and normal educational and intellectual functioning in young autistic children  J Consult Clin Psychol 1987;553- 9PubMedArticle
103.
McEachin  JJSmith  TLovaas  OI Long-term outcome for children with autism who received early intensive behavioral treatment  Am J Ment Retard 1993;97359- 372PubMed
104.
Schopler  EShort  AMesibov  G Relation of behavioral treatment to “normal functioning”: comment on Lovaas  J Consult Clin Psychol 1989;57162- 164PubMedArticle
105.
Smith  TEikeseth  SKlevstrand  MLovaas  O Intensive behavioral treatment for preschoolers with severe mental retardations and pervasive developmental disorder  Am J Ment Retard 1997;102238- 249PubMedArticle
106.
Sheinkopf  SJSiegel  B Home-based behavioral treatment of young children with autism  J Autism Dev Disord 1998;2815- 23PubMedArticle
107.
Eikeseth  SSmith  TJahr  EEldevik  S Intensive behavioral treatment at school for 4- to 7-year-old children with autism: a 1-year comparison controlled study  Behav Modif 2002;2649- 68PubMedArticle
108.
Howard  JSSparkman  CRCohen  HGGreen  GStanislaw  H A comparison of intensive behavior analytic and eclectic treatments for young children with autism  Res Dev Disabil 2005;26359- 383PubMedArticle
109.
Mesibov  GShea  VSchopler  E The TEACCH Approach to Autism Spectrum Disorders.  New York, NY Springer2005;
110.
Mesibov  G Formal and informal measures on the effectiveness of the TEACCH programme  Autism 1997;125- 35Article
111.
Mostert  MP Facilitated communication since 1995: a review of published studies  J Autism Dev Disord 2001;31287- 313PubMedArticle
112.
American Academy of Pediatrics, Committee on Children With Disabilities, Auditory integration training and facilitated communication for autism  Pediatrics 1998;102431- 433PubMedArticle
113.
Mudford  OCCross  BABreen  S  et al.  Auditory integration training for children with autism: no behavioral benefits detected  Am J Ment Retard 2000;105118- 129PubMedArticle
114.
Sinha  YSilove  NWheeler  DWilliams  K Auditory integration training and other sound therapies for autism spectrum disorders  Cochrane Database Syst Rev 2004; (1) CD003681PubMed
115.
Dawson  GWatling  R Interventions to facilitate auditory, visual, and motor integration in autism: a review of the evidence  J Autism Dev Disord 2000;30415- 421PubMedArticle
116.
Aman  MGNovotny  SSamango-Sprouse  C  et al.  Outcome measures for clinical drug trials in autism  CNS Spectr 2004;936- 47PubMed
117.
McCracken  JTMcGough  JShah  B  et al. Research Units on Pediatric Psychopharmacology Autism Network, Risperidone in children with autism and serious behavioral problems  N Engl J Med 2002;347314- 321PubMedArticle
118.
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network, Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity  Arch Gen Psychiatry 2005;621266- 1274PubMedArticle
119.
DeLong  GRTeague  LAMcSwain Kamran  M Effects of fluoxetine treatment in young children with idiopathic autism  Dev Med Child Neurol 1998;40551- 562PubMedArticle
120.
Jaselskis  CACook  EH  JrFletcher  KELeventhal  BL Clonidine treatment of hyperactive and impulsive children with autistic disorder  J Clin Psychopharmacol 1992;12322- 327PubMedArticle
121.
Steingard  RBiederman  J Lithium responsive manic-like symptoms in two individuals with autism and mental retardation  J Am Acad Child Adolesc Psychiatry 1987;26932- 935PubMedArticle
122.
American Academy of Pediatrics, Committee on Children With Disabilities, Technical report: the pediatrician's role in diagnosis and management of autistic spectrum disorder in children  Pediatrics 2001;1071221- 1226http://www.pediatrics.org/cgi/content/full/107/5/e85Accessed October 1, 2005Article
123.
Hyman  SLLevy  SE Autistic spectrum disorders: when traditional medicine is not enough  Contemp Pediatr 2000;17101- 116
124.
Kaptchuk  TJEisenberg  DM The persuasive appeal of alternative medicine  Ann Intern Med 1998;1291061- 1065PubMedArticle
125.
Bernard  SEnayati  ARedwood  LRoger  HBinstock  T Autism: a novel form of mercury poisoning  Med Hypotheses 2001;56462- 471PubMedArticle
126.
Aschner  MWalker  SJ The neuropathogenesis of mercury toxicity  Mol Psychiatry 2002;7(suppl 2)S40- S41PubMedArticle
127.
Hviid  AStellfeld  MWohlfahrt  JMelbye  M Association between thimerosal-containing vaccine and autism  JAMA 2003;2901763- 1766PubMedArticle
128.
Madsen  KMLauritsen  MBPedersen  CB  et al.  Thimerosal and the occurrence of autism: negative ecological evidence from Danish population-based data  Pediatrics 2003;112604- 606PubMedArticle
129.
Levy  SEHyman  SL Novel treatments for autistic spectrum disorders  Ment Retard Dev Disabil Res Rev 2005;11131- 142PubMedArticle
130.
Dietrich  KNWare  HHSalganik  M  et al.  Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry  Pediatrics 2004;11419- 24PubMedArticle
131.
Wakefield  AJMurch  SHAnthony  A Ileal lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder  Lancet 1998;351637- 641PubMedArticle
132.
Dales  LHammer  SJSmith  NJ Time trends in autism and in MMR immunization coverage in California  JAMA 2001;2851183- 1185PubMedArticle
133.
Madsen  KMHviid  AVestergaard  M  et al.  A population-based study of measles, mumps, and rubella vaccination and autism  N Engl J Med 2002;3471477- 1482PubMedArticle
134.
Taylor  BLingam  RSimmons  AStowe  JMiller  EAndrews  N Autism and MMR vaccination in North London: no causal relationship  Mol Psychiatry 2002;7(suppl 2)S7- S8PubMedArticle
135.
Honda  HShimizu  YRutter  M No effect of MMR withdrawal on the incidence of autism: a total population study  J Child Psychol Psychiatry 2005;46572- 579PubMedArticle
136.
Paterson  R MMR debate fall-out continues  Lancet Infect Dis 2004;4653PubMedArticle
137.
Pavone  LFiumara  ABottaro  GMazzone  DColeman  M Autism and celiac disease: failure to validate the hypothesis that a link might exist  Biol Psychiatry 1997;4272- 75PubMedArticle
138.
Kuddo  TNelson  KB How common are gastrointestinal disorders in children with autism?  Curr Opin Pediatr 2003;15339- 343PubMedArticle
139.
Black  CKaye  JAJick  H Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database  BMJ 2002;325419- 421PubMedArticle
140.
Hunter  LCO'Hare  AHerron  WJFisher  LAJones  GE Opioid peptides and dipeptidyl peptidase in autism  Dev Med Child Neurol 2003;45121- 128PubMedArticle
141.
Williams  KMMarshall  T Urinary protein patterns in autism as revealed by high resolution two-dimensional electrophoresis  Biochem Soc Trans 1992;20189SPubMed
142.
Le Couteur  ATrygstad  OEvered  CGillberg  CRutter  M Infantile autism and urinary excretion of peptides and protein-associated peptide complexes  J Autism Dev Disord 1988;18181- 190PubMedArticle
143.
Horvath  KPapadimitriou  JCRabsztyn  ADrachenberg  CTildon  JT Gastrointestinal abnormalities in children with autistic disorder  J Pediatr 1999;135559- 563PubMedArticle
144.
DelGiudice-Asch  GSimon  LSchmeidler  JCunningham-Rundles  CHollander  E A pilot open clinical trial of intravenous immunoglobulin in childhood autism  J Autism Dev Disord 1999;29157- 160PubMedArticle
×